1-10 of 10
Beihui Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics of 6 Cases of Overlapping Plasma Cell Disorders

Beihui Huang, Juan Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12537.
https://doi.org/10.1182/blood-2022-158745
Published: 2022
Journal Articles

Cytogenetic Evolution and Its Effect on Prognosis in Newly Diagnosed and Relapsed MM Patients

Yanjuan Li, Beihui Huang, Xiaozhe Li, Lifen Kuang, Meilan Chen, Junru Liu, Juan Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12527.
https://doi.org/10.1182/blood-2022-157389
Published: 2022
Journal Articles

A Novel Risk Scoring System to Predict Survival in Soft Tissue-Related Extramedullary Multiple Myeloma

Beihui Huang, Qing Wang, Wuping Li, Ying Zhao, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4749.
https://doi.org/10.1182/blood-2021-144837
Published: 2021
Journal Articles

Favorable Inductive Remission Rate of Decitabine Combined Chemotherapy on < 60-Years of Age MDS-like AML in the First Course

Fengqi Liu, MD, Xiuzhen Tong, MD, Zhenhai Zhou, MD, Dong Zheng, MD, Hehua Wang, MD, Junru Liu, MD, Beihui Huang, MD, Chang Su, MD, Waiyi Zou, MD, Duorong Xu, MD, Juan Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2711.
https://doi.org/10.1182/blood-2018-99-113748
Published: 2018
Journal Articles

Longitudinal Flow Cytometry Identified "Minimal Residual Disease" (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma

Jingli Gu, MD, Junru Liu, MD, Meilan Chen, PhD, Beihui Huang, MD, Juan Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5620.
https://doi.org/10.1182/blood-2018-99-113739
Published: 2018
Journal Articles

Scoring System for Predicting Risk of Relapse in Patients with Multiple Myeloma within Two Years after Stem Cell Transplantation

Beihui Huang, MD, Juan Li, MD, Jin Lu, MD, Yang Xiao, MD, Ying Zhao, MD, Hongming Huang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4531.
https://doi.org/10.1182/blood.V130.Suppl_1.4531.4531
Published: 2017
Journal Articles

Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

Beihui Huang, MD, Juan Li, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4532.
https://doi.org/10.1182/blood.V130.Suppl_1.4532.4532
Published: 2017
Journal Articles

Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

Beihui Huang, M.D., Juan Li, MD, PhD, Junru Liu, M.D., Dong Zheng, MD, PhD, Mei Chen, M.D., Zhenhai Zhou, M.D., Duorong Xu, M.D., Waiyi Zou, M.D.
Journal: Blood
Blood (2012) 120 (21): 5036.
https://doi.org/10.1182/blood.V120.21.5036.5036
Published: 2012
Journal Articles

Safety and Efficacy of Bortezomib and Dexamethasone (BD) in Multiple Myeloma as First-Line, Second-Line or Third-Line Treatment.

Juan Li, MD, Beihui Huang, MD, Ying Zhao, MD, Dong Zheng, MD, Shaokai Luo, MD
Journal: Blood
Blood (2007) 110 (11): 4817.
https://doi.org/10.1182/blood.V110.11.4817.4817
Published: 2007
Journal Articles

Imatinib Induces Apoptosis of Myeloma Cells by Inhibiting c-Kit Signaling Transduction.

Juan Li, MD, Beihui Huang, MD, Ying Zhao, MD, Shaokai Luo, MD
Journal: Blood
Blood (2007) 110 (11): 4738.
https://doi.org/10.1182/blood.V110.11.4738.4738
Published: 2007